Literature DB >> 11248240

Homing markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging.

P Houston1, J Goodman, A Lewis, C J Campbell, M Braddock.   

Abstract

Endothelial dysfunction plays a major role in the pathogenesis of atherosclerosis. Pro-inflammatory cytokines such as interleukin-1 beta and tumour necrosis factor alpha activate endothelial cells changing their resting phenotype to become pro-adhesive, pro-thrombotic and pro-atherogenic. Phage display in vivo biopanning has been used to identify peptide sequences that home to diseased regions of the vessel wall in low density lipoprotein receptor (LDLr) knockout mice. In LDLr knockout mice, peptide sequence determinants exhibiting organ specificity have been isolated. These sequences have applications for gene delivery, drug delivery and for improving contrast agents for vascular imaging.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248240     DOI: 10.1016/s0014-5793(01)02191-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.

Authors:  Kimberly A Kelly; Matthias Nahrendorf; Amy M Yu; Fred Reynolds; Ralph Weissleder
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature.

Authors:  Markus Essler; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  Targeting atherosclerosis by using modular, multifunctional micelles.

Authors:  David Peters; Mark Kastantin; Venkata Ramana Kotamraju; Priya P Karmali; Kunal Gujraty; Matthew Tirrell; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

Review 5.  Current state of in vivo panning technologies: Designing specificity and affinity into the future of drug targeting.

Authors:  Heather H Gustafson; Audrey Olshefsky; Meilyn Sylvestre; Drew L Sellers; Suzie H Pun
Journal:  Adv Drug Deliv Rev       Date:  2018-06-28       Impact factor: 15.470

6.  By-passing large screening experiments using sequencing as a tool to identify scFv fragments targeting atherosclerotic lesions in a novel in vivo phage display selection.

Authors:  Kamel Deramchia; Marie-Josee Jacobin-Valat; Jeanny Laroche-Traineau; Stephane Bonetto; Stephane Sanchez; Pierre Dos Santos; Philippe Massot; Jean-Michel Franconi; Pierre Martineau; Gisele Clofent-Sanchez
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

7.  Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.

Authors:  Hai-yan Hong; Hwa Young Lee; Wonjung Kwak; Jeongsoo Yoo; Moon-Hee Na; In Seop So; Tae-Hwan Kwon; Heon-Sik Park; Seung Huh; Goo Taeg Oh; Ick-Chan Kwon; In-San Kim; Byung-Heon Lee
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

8.  Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells.

Authors:  Maria Carolina Aquino Luque; Paulo Sampaio Gutierrez; Victor Debbas; Waleska Kerllen Martins; Pedro Puech-Leao; Georgia Porto; Verônica Coelho; Laurence Boumsell; Jorge Kalil; Beatriz Stolf
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

9.  CTHRSSVVC Peptide as a Possible Early Molecular Imaging Target for Atherosclerosis.

Authors:  Rosemeire A Silva; Ricardo J Giordano; Paulo S Gutierrez; Viviane Z Rocha; Martina Rudnicki; Patrick Kee; Dulcinéia S P Abdalla; Pedro Puech-Leão; Bruno Caramelli; Wadih Arap; Renata Pasqualini; José C Meneghetti; Fabio L N Marques; Menka Khoobchandani; Kattesh V Katti; Ademar B Lugão; Jorge Kalil
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.